What are the key quality control tests performed in a UTS laboratory for research-grade peptides?

In a UTS (Ultimate Testing Solutions) laboratory, the key quality control tests for research-grade peptides are centered on three non-negotiable pillars: purity verification, identity confirmation, and safety profiling. The most critical test is High-Performance Liquid Chromatography (HPLC) for purity, typically targeting a minimum of 98% for research-grade materials. This is paired with Mass Spectrometry (MS) for molecular weight confirmation, and a battery of safety tests including endotoxin limits (below 5 EU/mg) and sterility checks. Every batch must pass these before it’s released, and the data is compiled into a Certificate of Analysis (CoA) that researchers can verify independently. For a deeper look at how these protocols are executed, you can check out UTS Quality Control Laboratory Testing.

Let’s break down the specifics. Purity analysis via HPLC is the backbone. We run a reverse-phase C18 column with a gradient of acetonitrile and water, often with 0.1% trifluoroacetic acid. The detection is at 214 nm and 280 nm. The area under the curve for the main peak must be at least 98% of the total integrated area. For example, a 5 mg vial of a GHRP-2 analog should show a single peak with no shoulders or fronting. If you see a peak at 95%, that batch is rejected. We also calculate the peptide content from the HPLC data, factoring in the counterion (like acetate or TFA). A typical result might be 80% peptide content by weight, meaning the rest is water and salt. This is critical because if you’re dosing 1 mg, you need to know you’re actually getting 0.8 mg of the active molecule.

Mass Spectrometry is the identity check. We use Electrospray Ionization (ESI) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF). The measured mass must match the theoretical mass within 0.5 Da. For a peptide like BPC-157 (theoretical mass 1419.6 Da), we expect a main peak at 1419.6 ± 0.5. If we see a mass shift of 1 Da, it indicates a deletion or substitution error during synthesis. We also look for adducts like sodium (+22 Da) or potassium (+38 Da), which are common but should be minor. The MS spectrum should show a clean, single charge state envelope. If there’s a cluster of peaks, that’s a red flag for incomplete synthesis or degradation.

Endotoxin testing is non-negotiable for any peptide that might be used in cell culture or in vivo work. We use the Limulus Amebocyte Lysate (LAL) assay, either the gel-clot or chromogenic method. The limit is typically <5 EU/mg for research-grade peptides, but some labs push for <1 EU/mg for sensitive applications. For a 5 mg vial, that means the total endotoxin load must be under 25 EU. If the test shows 10 EU/mg, the batch is quarantined. We also run a sterility test using membrane filtration, incubating in Tryptic Soy Broth (TSB) and Fluid Thioglycollate Medium (FTM) at 30-35°C and 20-25°C for 14 days. No growth means the batch is sterile. If there’s turbidity, we do a Gram stain and subculture to identify the contaminant.

Heavy metal analysis is often overlooked but essential. We use Inductively Coupled Plasma Mass Spectrometry (ICP-MS) to screen for lead, arsenic, cadmium, and mercury. The limits are based on ICH Q3D guidelines, even for research-grade materials. For example, lead should be below 0.5 ppm, arsenic below 0.15 ppm. If a batch shows 1 ppm of lead, it’s rejected. This is especially important for peptides synthesized with metal catalysts, like those using Fmoc chemistry with palladium-based deprotection steps.

Water content is measured via Karl Fischer titration. Peptides are hygroscopic, and excess water can accelerate degradation. The target is typically <5% water by weight. For a lyophilized powder, we expect 2-3% water. If it’s 8%, the peptide is likely degrading faster, and the batch is flagged for stability testing. We also check residual solvents via Gas Chromatography (GC) with headspace injection. Common solvents like acetonitrile, methanol, and DMF must be below 500 ppm each. If we find 1000 ppm of acetonitrile, that’s a failure.

Appearance and solubility are simple but telling. The powder should be a uniform, off-white to white lyophilized cake. If it’s yellow, sticky, or has a strong odor, that’s a sign of degradation or contamination. We reconstitute a small sample in sterile water or PBS. It should dissolve completely within 30 seconds with gentle swirling. If there’s turbidity or particulate matter, we do a visual inspection under a light box and a particulate matter test using a light obscuration method. For a 5 mg vial, we expect <25 particles >10 µm and <3 particles >25 µm per vial.

Let’s talk about sequence confirmation. For novel peptides, we do Edman degradation or tandem MS (MS/MS) to sequence the first 10-20 amino acids. This ensures the primary structure is correct. For example, if you order a custom peptide with sequence H-Ala-Gly-Phe-Leu-Arg-OH, we need to see the correct fragmentation pattern in the MS/MS spectrum. If the Leu and Arg are swapped, the mass might be the same, but the activity will be different. We also use Amino Acid Analysis (AAA) after acid hydrolysis to quantify the molar ratios. The expected ratios should match the theoretical composition within 10%. If a peptide has 5 alanines and we find only 4, that’s a synthesis error.

Stability testing is a multi-point check. We store samples at 4°C, -20°C, and 40°C/75% relative humidity (accelerated conditions). At time points 0, 1, 3, 6, and 12 months, we re-run HPLC and MS. The degradation rate is calculated. For a stable peptide like TB-500, we expect <2% degradation per year at -20°C. For a fragile peptide like a cyclic disulfide, we might see 5% degradation in 6 months at 4°C. If the degradation exceeds 10% in 3 months at 40°C, the batch is considered unstable and not suitable for long-term storage.

We also do bioburden testing before the final sterile filtration. This is a total aerobic microbial count (TAMC) and total yeast and mold count (TYMC) using plate count methods. The limit is <100 CFU/g for TAMC and <10 CFU/g for TYMC. If the raw material has 500 CFU/g, we need to optimize the filtration step. For the final product, we do a bacterial endotoxin test (BET) again, because the filtration process can introduce endotoxins from the filter membrane.

Here’s a real-world data table from a recent batch of a common research peptide (MOTS-c, 5 mg vial):

Test	Method	Specification	Result	Pass/Fail
Purity (HPLC)	RP-HPLC, 214 nm	≥98%	99.2%	Pass
Mass (MS)	ESI-TOF	2174.5 ± 0.5 Da	2174.6 Da	Pass
Endotoxin	LAL chromogenic	<5 EU/mg	0.8 EU/mg	Pass
Sterility	Membrane filtration	No growth in 14 days	No growth	Pass
Water Content	Karl Fischer	<5%	2.1%	Pass
Heavy Metals (Pb)	ICP-MS	<0.5 ppm	<0.1 ppm	Pass
Residual Acetonitrile	GC headspace	<500 ppm	120 ppm	Pass
Appearance	Visual	White lyophilized cake	White cake	Pass
Solubility	Reconstitution in water	Clear solution within 30 sec	Clear in 15 sec	Pass

This is the kind of data that gets released with every batch. Researchers can compare it to the CoA from the supplier. If the numbers don’t match, the batch is suspect. For example, if a supplier claims 99% purity but their HPLC chromatogram shows a broad peak with a tailing factor >2, that’s not 99% purity. It’s likely 95% with poor column performance. We calculate the tailing factor (T) and theoretical plates (N) for every HPLC run. A good column should give T between 0.8 and 1.5 and N > 5000 for the main peak. If T is 2.5, the peak is distorted, and the purity calculation is unreliable.

Another critical angle is batch-to-batch consistency. We track the purity and mass of every batch over time. For a given peptide, the standard deviation of purity across 20 batches should be less than 0.5%. If we see a batch at 97.5% and the next at 98.5%, that’s normal. But if one batch drops to 95%, we investigate the raw material or synthesis step. We also do comparative testing against a reference standard. For common peptides like Melanotan II, we have a house standard that’s been fully characterized by NMR and MS. Every new batch must match the reference standard’s retention time within 0.1 minutes and the MS spectrum within 0.3 Da.

For peptide content, we use a combination of UV spectroscopy and HPLC. The UV absorption at 280 nm (for tryptophan, tyrosine, phenylalanine) gives a quick estimate of concentration. But for accurate content, we use the HPLC peak area and compare it to a standard curve. The standard curve is prepared with a certified reference material, like a 1 mg/mL solution of the peptide in water. The correlation coefficient (R²) must be >0.999. If the R² is 0.995, the curve is not reliable, and we re-prepare it.

Disulfide bond analysis is a specialized test for peptides with cysteine residues. We use Ellman’s reagent (DTNB) to detect free thiols. If the peptide should have a disulfide bond, we expect <2% free thiols. If we find 10% free thiols, the oxidation is incomplete. We also do reduction and alkylation followed by MS to confirm the disulfide connectivity. For a peptide with two disulfide bonds, like a conotoxin, the fragmentation pattern in MS/MS should show the correct cross-links. If the pattern is wrong, the peptide is misfolded and inactive.

We also test for aggregation using Dynamic Light Scattering (DLS). The hydrodynamic radius should be consistent with a monomeric peptide. If we see a peak at 100 nm, that’s an aggregate. For a peptide like amyloid beta, aggregation is a known issue, but for research-grade peptides, we want <1% aggregates by mass. We use Size Exclusion Chromatography (SEC) as a confirmatory test. The SEC chromatogram should show a single peak at the expected retention time. If there’s a peak in the void volume, that’s a high molecular weight aggregate.

Finally, we do a pH check on the reconstituted solution. The pH should be between 4.5 and 6.5 for most peptides. If it’s below 3 or above 8, the peptide may be degraded or the buffer is wrong. We also measure osmolality for peptides intended for injection research. The target is 280-320 mOsm/kg. If it’s 500 mOsm/kg, the solution is hypertonic and could cause cell lysis in cell culture experiments.

These tests are not just a checklist. They’re a system. Every failure triggers a root cause analysis. For example, if a batch fails the endotoxin test, we check the raw material, the water used for synthesis, the lyophilizer, and the vial stoppers. If the water is the source, we replace the reverse osmosis system. If the stoppers are the source, we switch to a different supplier. The goal is zero failures in the final product. That’s what research-grade means: it’s not just a label, it’s a process.